ArticleJournal of clinical and translational science2026
Costs and cost-effectiveness of a culturally adapted diabetes self-management and education program for Marshallese adults.
Article in Journal of clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Culturally adapted diabetes self-management education (DSME) programs are effective in improving glycemic control and diabetes outcomes among minority populations, but data on program costs and cost-effectiveness are limited. This study aimed to assess the cost and cost-effectiveness of a culturally adapted DSME (adapted DSME) compared to a standard DSME model among Marshallese adults with type 2 diabetes (T2D). Methods: Retrospective cost and cost-effectiveness analyses (CEA) were conducted using data from the community-based trial, conducted between May 2015 and May 2018. We applied an activity-based costing approach to quantify the implementation resources. The CEA was performed using an incremental implementation cost-effectiveness ratio (ICER) measure, expressed as costs for additional unit change in hemoglobin A1c (HbA1c) over 12 months between adapted DSME and standard DSME. We further estimated the replication costs for the adapted DSME for implementation in other settings. The analysis was conducted from a community implementation perspective with a one-year time horizon. Results: Total program costs were $1,227 per participant for the adapted DSME and $122 per participant for the standard DSME. The ICER was $1434 per additional unit reduction in HbA1c. Replication costs for the adapted DSME were estimated at $125,473 (range: $62,737-$188,210). Conclusions: The culturally adapted DSME has been shown to be effective in managing T2D and may serve as a cost-effective lifestyle intervention for Marshallese individuals beyond the trial period. Future research should assess its broader economic and health impacts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.